Publications (401) ELIECER COTO GARCIA publications

2025

  1. Assessing the association between common functional Nuclear Factor Kappa-b gene polymorphisms (NFKB1, NFKBIZ, NFKBIA) and Alzheimer´s disease

    Behavioural Brain Research, Vol. 476

2024

  1. Chromosome-Y haplogroups in Asturias (Northern Spain) and their association with severe COVID-19

    Molecular Genetics and Genomics, Vol. 299, Núm. 1

  2. Identification of host endotypes using peripheral blood transcriptomics in a prospective cohort of patients with endocarditis

    International Journal of Infectious Diseases, Vol. 148

  3. Immunoglobulin genes and severity of COVID-19

    Immunogenetics, Vol. 76, Núm. 3, pp. 213-217

  4. Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  5. NFKB1 variants were associated with the risk of Parkinson´s disease in male

    Journal of Neural Transmission, Vol. 131, Núm. 7, pp. 773-779

  6. PCSK9 gene variations in the clinical setting of premature cardiovascular disease: A critical appraisal

    International Journal of Cardiology, Vol. 413

  7. Retrospective variant reclassification and resequencing in hypertrophic cardiomyopathy: a reference unit centre experience

    European Journal of Preventive Cardiology, Vol. 31, Núm. 6, pp. e38-e41

  8. Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing

    International Journal of Cardiology, Vol. 408

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Age-dependent effect of the IFIH1/MDA5 gene variants on the risk of critical COVID-19

    Immunogenetics, Vol. 75, Núm. 2, pp. 91-98

  3. Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry

    Journal of Clinical Medicine, Vol. 12, Núm. 14

  4. Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  5. Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence

    Journal of Clinical Medicine, Vol. 12, Núm. 6

  6. Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  7. The IFIH1/MDA5 rs1990760 Gene Variant (946Thr) Differentiates Early- vs. Late-Onset Skin Disease and Increases the Risk of Arthritis in a Spanish Cohort of Psoriasis

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

  8. Transcriptomic clustering of critically ill COVID-19 patients

    The European respiratory journal, Vol. 61, Núm. 1

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Association of the Genetic Variation in the Long Non‐Coding RNA FENDRR with the Risk of Developing Hypertrophic Cardiomyopathy

    Life, Vol. 12, Núm. 6

  3. Common mitochondrial haplogroups as modifiers of the onset-age for critical COVID-19

    Mitochondrion, Vol. 67, pp. 1-5